Wasp venom allergy immunotherapy - Allergopharma
Alternative Names: Wasp venom allergy vaccine - AllergopharmaLatest Information Update: 08 Jun 2015
At a glance
- Originator Allergopharma
- Class Allergens; Antiallergics; Hymenoptera allergy immunotherapies; Immunotherapies; Venoms
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 08 Jun 2015 Discontinued - Phase-III for Hypersensitivity in Germany (unspecified route)